Blockade of the TREM-1 signaling by a short inhibitory peptide (LP17 and LR12) reduced tissue injury during mesenteric IR and myocardial infarction, emphasizing the potential therapeutic benefit of TREM-1 inhibition in sterile inflammation12, 13. Here, TREM1 is linked to myocardial infarction.